Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

247 public trials 61 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT07155174

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Yale University School of Medicine /ID# 278181 New Haven, Connecticut, United States
  • Ocala Oncology Center /ID# 278269 Ocala, Florida, United States
  • Moffitt Cancer Center /ID# 277573 Tampa, Florida, United States
  • Fort Wayne Medical Oncology And Hematology /ID# 277336 Fort Wayne, Indiana, United States
View all 68 locations
View Trial Details
Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07365241

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 280198 Mobile, Alabama, United States
  • City Of Hope - Phoenix /ID# 281323 Goodyear, Arizona, United States
  • City of Hope National Medical Center /ID# 281322 Duarte, California, United States
View all 72 locations
View Trial Details
Recruiting

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Genital Diseases, +28 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Santa Monica Santa Monica, California, United States
View all 37 locations
View Trial Details
Recruiting

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

NCT07778316

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Cancer and Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
  • Shanghai Pulmonary Hospital Shanghai, China
  • University of Florida Health Cancer Center at Orlando Health Orlando, Florida, United States
  • Oncology Hematology West PC Omaha, Nebraska, United States
View Trial Details

Related conditions